- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Impact of Government Policies and Proposals on Community Oncologists
The federal government has been releasing a number of policies and proposals that will affect care delivery and are aimed at rising costs of care and prescription drugs.
The federal government has been releasing a number of policies and proposals that will affect care delivery and are aimed at rising costs of care and prescription drugs.
Ted Okon, executive director of the Community Oncology Alliance (COA), sat down with Managed Care Cast to discuss a number of policies affecting COA’s members, including proposals around chimeric antigen receptor T-cell therapies, pharmacy benefit managers, and the Oncology Care Model.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
CMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy
Ted Okon on Policy Priorities for COA in 2019
COA's OCM 2.0: Moving Toward a Universal Payment Model
More Than 300 Groups Seek Halt to CMS' Plans for Global Drug Pricing Index
Trump Proposes Allowing Medicare to Base Drug Prices on What Other Countries Pay
HHS Proposes to End Drug Rebates in Medicare, Medicaid Managed Care
Read more about the stories in this podcast:
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Clinical Trials Won’t Cause Financial Harm for Practices in Medicare Payment Models, Study Finds
June 28th 2024Ishwaria Subbiah, MD, of SCRI Oncology Partners, discusses new findings presented at ASCO 2024. This interview will appear in the annual ASCO recap issue of Evidence-Based Oncology.
Read More
